Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$24.50
$23.48
$21.28
$27.15
$5.40B0.5168 shsN/A
Howden Joinery Group Plc stock logo
HWDJY
Howden Joinery Group
$43.44
$42.31
$31.30
$43.44
$5.97B0.6735 shsN/A
Jiangsu Expressway Company Limited stock logo
JEXYY
Jiangsu Expressway
$19.30
$20.11
$17.16
$20.93
$4.86B0.35142 shs2 shs
MERLIN ENTERTAI/S stock logo
MERLY
MERLIN ENTERTAI/S
$11.67
$11.67
$7.78
$11.89
$5.97B0.8222,301 shs149 shs
Orion Oyj stock logo
ORINY
Orion Oyj
$17.50
$18.36
$17.50
$24.40
$4.94B0.2353 shsN/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
0.00%+9.72%+1.03%+2.00%+7.04%
Howden Joinery Group Plc stock logo
HWDJY
Howden Joinery Group
0.00%0.00%+4.67%+7.25%+25.04%
Jiangsu Expressway Company Limited stock logo
JEXYY
Jiangsu Expressway
0.00%-0.68%-2.30%+0.42%-1.81%
MERLIN ENTERTAI/S stock logo
MERLY
MERLIN ENTERTAI/S
0.00%0.00%0.00%0.00%0.00%
Orion Oyj stock logo
ORINY
Orion Oyj
0.00%0.00%-2.78%-22.82%-28.28%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Howden Joinery Group Plc stock logo
HWDJY
Howden Joinery Group
N/AN/AN/AN/AN/AN/AN/AN/A
Jiangsu Expressway Company Limited stock logo
JEXYY
Jiangsu Expressway
N/AN/AN/AN/AN/AN/AN/AN/A
MERLIN ENTERTAI/S stock logo
MERLY
MERLIN ENTERTAI/S
N/AN/AN/AN/AN/AN/AN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
2.00
HoldN/AN/A
Howden Joinery Group Plc stock logo
HWDJY
Howden Joinery Group
N/AN/AN/AN/A
Jiangsu Expressway Company Limited stock logo
JEXYY
Jiangsu Expressway
N/AN/AN/AN/A
MERLIN ENTERTAI/S stock logo
MERLY
MERLIN ENTERTAI/S
N/AN/AN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
2.00
HoldN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$2.88B1.88$3.33 per share7.36$10.03 per share2.44
Howden Joinery Group Plc stock logo
HWDJY
Howden Joinery Group
$2.87B2.08$4.45 per share9.77$7.76 per share5.60
Jiangsu Expressway Company Limited stock logo
JEXYY
Jiangsu Expressway
N/AN/AN/AN/AN/AN/A
MERLIN ENTERTAI/S stock logo
MERLY
MERLIN ENTERTAI/S
$2.25B2.65$1.04 per share11.26$4.56 per share2.56
Orion Oyj stock logo
ORINY
Orion Oyj
$1.29B3.84$1.48 per share11.81$3.39 per share5.16

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$190MN/A0.0011.19N/AN/AN/AN/AN/A
Howden Joinery Group Plc stock logo
HWDJY
Howden Joinery Group
$316.60MN/A0.0015.85N/AN/AN/AN/AN/A
Jiangsu Expressway Company Limited stock logo
JEXYY
Jiangsu Expressway
N/AN/A0.00N/AN/AN/AN/AN/A
MERLIN ENTERTAI/S stock logo
MERLY
MERLIN ENTERTAI/S
$307MN/A0.00N/AN/AN/AN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
$234.62M$0.8420.8317.16N/A17.74%26.81%16.09%N/A

Latest HKMPF, ORINY, MERLY, JEXYY, and HWDJY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/25/2024Q1 2024
Orion Oyj stock logo
ORINY
Orion Oyj
N/A$0.17+$0.17$0.17N/A$334.95 million
2/13/2024Q4 2023
Orion Oyj stock logo
ORINY
Orion Oyj
N/A$0.29+$0.29$0.29N/A$345.76 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$0.943.84%N/AN/AN/A
Howden Joinery Group Plc stock logo
HWDJY
Howden Joinery Group
$1.563.59%N/AN/AN/A
Jiangsu Expressway Company Limited stock logo
JEXYY
Jiangsu Expressway
$1.145.91%N/AN/AN/A
MERLIN ENTERTAI/S stock logo
MERLY
MERLIN ENTERTAI/S
$0.242.06%N/AN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
$0.362.06%N/A42.86%N/A

Latest HKMPF, ORINY, MERLY, JEXYY, and HWDJY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/15/2024
Howden Joinery Group Plc stock logo
HWDJY
Howden Joinery Group
$0.78024/11/20244/12/20246/10/2024
3/6/2024
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$0.473/20/20243/22/20245/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
0.47
1.57
0.90
Howden Joinery Group Plc stock logo
HWDJY
Howden Joinery Group
N/AN/AN/A
Jiangsu Expressway Company Limited stock logo
JEXYY
Jiangsu Expressway
N/AN/AN/A
MERLIN ENTERTAI/S stock logo
MERLY
MERLIN ENTERTAI/S
N/AN/AN/A
Orion Oyj stock logo
ORINY
Orion Oyj
0.21
3.10
1.59

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
8,800220.23 millionN/ANot Optionable
Howden Joinery Group Plc stock logo
HWDJY
Howden Joinery Group
12,000137.38 millionN/ANot Optionable
Jiangsu Expressway Company Limited stock logo
JEXYY
Jiangsu Expressway
4,754251.89 millionN/ANot Optionable
MERLIN ENTERTAI/S stock logo
MERLY
MERLIN ENTERTAI/S
28,000511.04 millionN/ANot Optionable
Orion Oyj stock logo
ORINY
Orion Oyj
3,527282.27 millionN/ANot Optionable

HKMPF, ORINY, MERLY, JEXYY, and HWDJY Headlines

SourceHeadline
Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025
finance.yahoo.com - May 7 at 3:22 AM
Orion Oyj (OTCMKTS:ORINY) Reaches New 1-Year Low at $17.50Orion Oyj (OTCMKTS:ORINY) Reaches New 1-Year Low at $17.50
marketbeat.com - May 6 at 11:22 PM
Orion Corporation: Managers’ transactions – Henrik StenqvistOrion Corporation: Managers’ transactions – Henrik Stenqvist
finance.yahoo.com - May 6 at 9:14 AM
Orion selects bispecific antibodies from Alligator Bioscience collaborationOrion selects bispecific antibodies from Alligator Bioscience collaboration
bioworld.com - April 30 at 7:36 AM
Orion Oyj (OTCMKTS:ORINY) Hits New 12-Month Low at $17.50Orion Oyj (OTCMKTS:ORINY) Hits New 12-Month Low at $17.50
marketbeat.com - April 29 at 7:32 PM
Orion Group Interim Report January–March 2024Orion Group Interim Report January–March 2024
finance.yahoo.com - April 25 at 8:45 AM
Orion Group Interim Report January–March 2024Orion Group Interim Report January–March 2024
finance.yahoo.com - April 25 at 8:45 AM
Orion Minerals Ltd (ASX: ORN) - Share Price and ResearchOrion Minerals Ltd (ASX: ORN) - Share Price and Research
intelligentinvestor.com.au - April 24 at 3:08 PM
Orion Oyj (OTCMKTS:ORINY) Hits New 52-Week Low at $17.50Orion Oyj (OTCMKTS:ORINY) Hits New 52-Week Low at $17.50
marketbeat.com - April 22 at 7:38 PM
Orion Oyj (OTCMKTS:ORINY) Reaches New 1-Year Low at $18.00Orion Oyj (OTCMKTS:ORINY) Reaches New 1-Year Low at $18.00
marketbeat.com - April 15 at 8:20 PM
Orion Oyj goes ex dividend tomorrowOrion Oyj goes ex dividend tomorrow
msn.com - March 20 at 10:18 AM
ORN Orion Group Holdings, Inc.ORN Orion Group Holdings, Inc.
seekingalpha.com - March 19 at 8:29 AM
Orion Corporation: Managers’ transactions – Juhani KankaanpääOrion Corporation: Managers’ transactions – Juhani Kankaanpää
finance.yahoo.com - March 4 at 7:42 AM
Orion Oyj just downgraded at Jefferies, heres whyOrion Oyj just downgraded at Jefferies, here's why
realmoney.thestreet.com - February 26 at 1:52 PM
Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globallyOrion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally
finance.yahoo.com - February 22 at 9:34 AM
Orion Oyj B (ORNBV)Orion Oyj B (ORNBV)
investing.com - February 21 at 12:50 AM
Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, FinlandOrion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland
finance.yahoo.com - February 19 at 7:31 AM
Orion Group Financial Statement Release January–December 2023Orion Group Financial Statement Release January–December 2023
finance.yahoo.com - February 13 at 7:13 AM
119,021 Orion Corporation A shares converted into B shares119,021 Orion Corporation A shares converted into B shares
finance.yahoo.com - February 7 at 4:20 PM
Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in painOrion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain
finance.yahoo.com - January 29 at 9:02 AM
Orion publishes Financial Statement Release for 2023 and holds a webcast on 13 February 2024Orion publishes Financial Statement Release for 2023 and holds a webcast on 13 February 2024
finance.yahoo.com - January 29 at 9:02 AM
Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024
finance.yahoo.com - January 27 at 3:44 AM
Insurance portfolio of Orion Pension Fund’s B fund transferred to an external pension insurance company – the transfer has approximately EUR 31 million positive impact on Orion’s result in 2023Insurance portfolio of Orion Pension Fund’s B fund transferred to an external pension insurance company – the transfer has approximately EUR 31 million positive impact on Orion’s result in 2023
finance.yahoo.com - January 11 at 12:08 PM
Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2024 Annual General MeetingRecommendation by the Orion Nomination Committee on the proposals to be submitted to the 2024 Annual General Meeting
finance.yahoo.com - January 11 at 12:08 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Hikma Pharmaceuticals logo

Hikma Pharmaceuticals

OTCMKTS:HKMPF
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Howden Joinery Group logo

Howden Joinery Group

OTCMKTS:HWDJY
Howden Joinery Group Plc supplies various kitchen, joinery, and hardware products in the United Kingdom, France, Belgium, and the Republic of Ireland. The company's product portfolio worktops, sinks and taps, flooring, appliances, and handles; internal and external doors, including fire doors, flooring, stair parts, and general joinery items; and cooking, cleaning, and cooling appliances. Howden Joinery Group Plc was incorporated in 1987 and is based in London, the United Kingdom.
Jiangsu Expressway logo

Jiangsu Expressway

OTCMKTS:JEXYY
Jiangsu Expressway Company Limited engages in investment, construction, operation, and management of toll roads and bridges in the People's Republic of China. The company operates the Jiangsu section of Shanghai-Nanjing Expressway, Ningchang Expressway, Zhenli Expressway, Guangjing Expressway, Xicheng Expressway, Xiyi Expressway, Zhendan Expressway, Yanjiang Expressway, Jiangyin Bridge, Sujiahang Expressway, Changyi Expressway, Yichang Expressway, and Wufengshan Bridge. As of December 31, 2022, it operated 17 road and bridge projects; and owned approximately 910 kilometers of roads and bridges. The company also offers passenger transportation; and ancillary services, including refueling, catering, shopping, automobile maintenance, advertising and accommodation, etc. In addition, it engages in the real estate development; and sale of electricity and petroleum products. The company was incorporated in 1992 and is headquartered in Nanjing, China. Jiangsu Expressway Company Limited is a subsidiary of JiangSu Communications Holding Co., Ltd.
MERLIN ENTERTAI/S logo

MERLIN ENTERTAI/S

OTCMKTS:MERLY
Merlin Entertainments plc operates visitor attraction places worldwide. The company operates midway attractions under the Madame Tussauds, The Eye Brand, SEA LIFE, The Dungeons, LEGOLAND Discovery Centres, Seal Sanctuaries, Shreks Adventure, Blackpool Tower, WILD LIFE, Australian Treetop Adventures, Hotham Alpine Resort, Falls Creek, and Little BIG City brands. It also operates resort theme parks under the Alton Towers, Chessington World of Adventures, Gardaland, Heide Park, THORPE PARK Resort, and Warwick Castle brands; and LEGOLAND parks under the LEGOLAND Billund, LEGOLAND Windsor, LEGOLAND California, LEGOLAND Deutschland, LEGOLAND Florida, LEGOLAND Malaysia, LEGOLAND Dubai, and LEGOLAND Japan brands. The company operates approximately 120 attractions, 18 hotels, and 6 holiday villages in 25 countries and across 4 continents. Merlin Entertainments plc was founded in 1999 and is headquartered in Poole, the United Kingdom.
Orion Oyj logo

Orion Oyj

OTCMKTS:ORINY
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. Further, the company has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.